Postoperative pain is a major issue with subcutaneous implantable cardioverter defibrillators (S‐ICD). In 2020, we introduced intravenous patient‐controlled analgesia (IV‐PCA) in addition to the conventional, request‐based analgesia for postoperative pain… Click to show full abstract
Postoperative pain is a major issue with subcutaneous implantable cardioverter defibrillators (S‐ICD). In 2020, we introduced intravenous patient‐controlled analgesia (IV‐PCA) in addition to the conventional, request‐based analgesia for postoperative pain control in S‐ICD. To determine the effect and safety, we quantitatively assessed the effect of IV‐PCA after S‐ICD surgery over conventional methods.
               
Click one of the above tabs to view related content.